Rhinosinusitis is inflammation of the paranasal sinuses and nasal cavity. It can result from viral, bacterial, or fungal infections with viral being the most common. Infection extension beyond the sinuses and cavities can result in bacterial rhinosinusitis complications (i.e, periorbital edema, meningitis). Sinusitis affects 1 in 8 adults in the United States and accounts for more outpatient antibiotic prescriptions than any other diagnosis. Sinusitis can be further categorized as acute, subacute, chronic, and recurrent based on symptom duration. Whether viral or bacterial, most cases of uncomplicated acute rhinosinusitis self-resolve with supportive care alone but antibiotic therapy should be considered in certain cases of acute bacterial rhinosinusitis.
Cardinal symptoms of Acute Rhinosinusitis (ARS)
Note: ARS is a clinical diagnosis based on the presence of cardinal symptoms. Imaging is not needed. Distinguishing between a viral or bacterial infection is based more on duration and course of symptomatology. Color of nasal discharge alone has poor predictability for predicting the likelihood of a bacterial sinus infection.
Complications of bacterial sinusitis occur when infection spreads beyond the nasal sinuses into surrounding areas including the central nervous system, orbits, and adjacent tissue spaces
Note: Consider imaging with urgent referral to specialist or immediate emergency department evaluation if signs of systemic toxicity, peri-orbital involvement, meningeal symptoms, or concern for invasive fungal infection
Risk factors for Complications from ABRS
First determine if viral or bacterial etiology
If Acute Viral Rhinosinusitis offer supportive care
If Acute Bacterial Rhinosinusitis offer antibiotic therapy or period of ‘watchful waiting’ in conjunction with supportive care
When to initiate antibiotics
Are you an
Get specially curated clinical summaries delivered to your inbox every week for free
Please log in to ObGFirst to access the 2T US Atlas
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst
You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site